✦ LIBER ✦

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

✍ Scribed by Han Christine Ngoc Nguyen; Wanling Xie; Ming Yang; Chen-Lin Hsieh; Sarah Drouin; Gwo-Shu Mary Lee; Philip W. Kantoff

Book ID: 115561366
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 402 KB
Volume: 73
Category: Article
ISSN: 0270-4137
DOI: 10.1002/pros.22572

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1103 POSTER Overexpression of MiR-141 an

1103 POSTER Overexpression of MiR-141 and MiR-126 Distinguishes Metastatic Castration Resistant Prostate Cancer (mCRPC) From Localized Prostate Cancer (PCa) and Controls in Human Plasma

✍ R.J. Macfarlane; A. Watahiki; Y.Z. Wang; K.N. Chi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Biomarkers in the Management and Treatme

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

✍ Andrew J. Armstrong; Mario A. Eisenberger; Susan Halabi; Stephane Oudard; David 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 770 KB

A review of expression profiling of circ

A review of expression profiling of circulating microRNAs in men with prostate cancer

✍ Brian D. Kelly; Nicola Miller; Nuala A. Healy; Kilian Walsh; Michael J. Kerin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

A REVIEW OF EXPRESSION PROFILING OF CIRC

A REVIEW OF EXPRESSION PROFILING OF CIRCULATING MICRORNAs IN MEN WITH PROSTATE CANCER

✍ Klaus Jung 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

680 PREDICTION OF FAVOURABLE OUTCOME AND

680 PREDICTION OF FAVOURABLE OUTCOME AND RATIONAL INDICATION OF DOCETAXEL RECHALLENGE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER

✍ Heck, Matthias; Thalgott, Mark; Retz, Margitta; Wolf, Petra; Maurer, Tobias; Gsc 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 81 KB

The development of risk groups in men wi

The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival

✍ Andrew J. Armstrong; Ian F. Tannock; Ronald de Wit; Daniel J. George; Mario Eise 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 330 KB